Knights Group Holdings PLC
LSE:KGH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Knights Group Holdings PLC
LSE:KGH
|
UK |
|
Jeil Pharma Holdings Inc
KRX:002620
|
KR |
Balance Sheet
Balance Sheet Decomposition
Knights Group Holdings PLC
Knights Group Holdings PLC
Balance Sheet
Knights Group Holdings PLC
| Apr-2018 | Apr-2019 | Apr-2020 | Apr-2021 | Apr-2022 | Apr-2023 | Apr-2024 | Apr-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
2
|
5
|
13
|
5
|
4
|
4
|
5
|
6
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
5
|
6
|
|
| Cash Equivalents |
2
|
5
|
13
|
5
|
4
|
4
|
0
|
0
|
|
| Total Receivables |
15
|
22
|
44
|
54
|
60
|
62
|
67
|
83
|
|
| Accounts Receivables |
15
|
22
|
44
|
54
|
58
|
62
|
66
|
82
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
2
|
0
|
1
|
1
|
|
| Other Current Assets |
0
|
3
|
5
|
6
|
7
|
7
|
7
|
10
|
|
| Total Current Assets |
17
|
30
|
61
|
65
|
71
|
74
|
79
|
99
|
|
| PP&E Net |
2
|
3
|
29
|
50
|
51
|
48
|
49
|
70
|
|
| PP&E Gross |
0
|
3
|
29
|
50
|
51
|
48
|
49
|
70
|
|
| Accumulated Depreciation |
0
|
2
|
4
|
9
|
17
|
24
|
24
|
30
|
|
| Intangible Assets |
20
|
20
|
29
|
32
|
30
|
28
|
25
|
33
|
|
| Goodwill |
0
|
27
|
40
|
48
|
52
|
60
|
62
|
73
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
1
|
2
|
4
|
3
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
27
|
40
|
48
|
52
|
60
|
62
|
73
|
|
| Total Assets |
39
N/A
|
79
+103%
|
160
+101%
|
194
+22%
|
205
+6%
|
212
+3%
|
219
+3%
|
279
+27%
|
|
| Liabilities | |||||||||
| Accounts Payable |
6
|
1
|
3
|
12
|
5
|
6
|
6
|
7
|
|
| Accrued Liabilities |
0
|
9
|
14
|
16
|
15
|
13
|
13
|
17
|
|
| Short-Term Debt |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
3
|
4
|
6
|
7
|
6
|
7
|
|
| Other Current Liabilities |
1
|
6
|
9
|
6
|
6
|
7
|
6
|
8
|
|
| Total Current Liabilities |
7
|
16
|
29
|
40
|
31
|
32
|
31
|
38
|
|
| Long-Term Debt |
28
|
19
|
50
|
63
|
74
|
72
|
76
|
118
|
|
| Deferred Income Tax |
1
|
3
|
5
|
6
|
8
|
8
|
8
|
11
|
|
| Other Liabilities |
0
|
2
|
0
|
3
|
7
|
7
|
4
|
6
|
|
| Total Liabilities |
36
N/A
|
40
+11%
|
84
+108%
|
112
+33%
|
120
+7%
|
119
-1%
|
119
0%
|
174
+46%
|
|
| Equity | |||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
3
|
7
|
10
|
14
|
11
|
17
|
25
|
30
|
|
| Additional Paid In Capital |
0
|
32
|
66
|
68
|
74
|
75
|
75
|
75
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Total Equity |
3
N/A
|
39
+1 303%
|
76
+93%
|
83
+9%
|
86
+4%
|
93
+8%
|
100
+8%
|
105
+4%
|
|
| Total Liabilities & Equity |
39
N/A
|
79
+103%
|
160
+101%
|
194
+22%
|
205
+6%
|
212
+3%
|
219
+3%
|
279
+27%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
72
|
73
|
82
|
83
|
85
|
86
|
86
|
86
|
|